Dermatologic masks of Langerhans cell histiocytosis. Case report
- Authors: Belysheva T.S.1, Valiev T.T.1,2, Murashkin N.N.2,3,4
-
Affiliations:
- Blokhin National Medical Research Center of Oncology
- Sechenov First Moscow State Medical University (Sechenov University)
- National Medical Research Center for Children's Health
- Central State Medical Academy of the Administrative Department of the President of the Russian Federation
- Issue: Vol 24, No 8 (2022)
- Pages: 541-546
- Section: Articles
- URL: https://ogarev-online.ru/2075-1753/article/view/112311
- DOI: https://doi.org/10.26442/20751753.2022.8.201817
- ID: 112311
Cite item
Full Text
Abstract
Langerhans cell histiocytosis (LCH) is a rare pathology in pediatric age with heterogeneous clinical presentation in skeletal system, skin, central nervous system, liver, spleen, lungs, lymph nodes and bone marrow. Therefore, a number of diagnostic mistakes increase and inadequate therapy administrates. For a diagnostic period, a try at treatment, LCH disseminates with organs and systems involvement and at the moment of morpho-immunologic diagnosis verification, a disease characterizes as multiorgan multiple site affection, which decreased survival rate. In the current issue a clinical case of LCH with mistaken prolonged (2 year) atopic dermatitis anamneses is presented. The absence of pronounced effect of topical therapy along with nontypical for atopic dermatitis became not an indication for skin biopsy. After appearance of systemic symptoms with anemia, leuko- and thrombocytopenia became an evidence for pediatric oncologist-hematologist consultation.
Full Text
##article.viewOnOriginalSite##About the authors
Tatiana S. Belysheva
Blokhin National Medical Research Center of Oncology
Email: klinderma@bk.ru
ORCID iD: 0000-0001-5911-553X
SPIN-code: 2645-4049
D. Sci. (Med.)
Russian Federation, MoscowTimur T. Valiev
Blokhin National Medical Research Center of Oncology; Sechenov First Moscow State Medical University (Sechenov University)
Author for correspondence.
Email: timurvaliev@mail.ru
ORCID iD: 0000-0002-1469-2365
D. Sci. (Med.)
Russian Federation, Moscow; MoscowNikolay N. Murashkin
Sechenov First Moscow State Medical University (Sechenov University); National Medical Research Center for Children's Health; Central State Medical Academy of the Administrative Department of the President of the Russian Federation
Email: m_nn2001@mail.ru
ORCID iD: 0000-0003-2252-8570
SPIN-code: 5906-9724
D. Sci. (Med.)
Russian Federation, Moscow; Moscow; MoscowReferences
- Krooks J, Minkov M, Weatherall AG, Raton B. Langerhans cell histiocytosis in children. History, classification, pathobiology, clinical manifestations, and prognosis. J Am Acad Dermatol. 2018;78(6):1035-44.
- Валиев Т.Т., Махонова Л.А., Ковригина А.М., и др. Случай врожденного лангергансоклеточного гистиоцитоза у ребенка раннего возраста. Онкогематология. 2011;6(2):19-22 [Valiev TT, Makhonova LA, Kovrigina AM, et al. Case of congenital Langerhans cells histiocytosis in an infant. Oncohematology. 2011;6(2):19-22 (in Russian)].
- Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60:175-84.
- Li Z, Yanqiu L, Yan W, et al. Two case report studies of Langerhans cell histiocytosis with an analysis of 918 patients of Langerhans cell histiocytosis in literatures published in China. Int J Dermatol. 2010;49:1169-74.
- Weitzman S, Egeler RM. Langerhans cell histiocytosis: update for the pediatrician. Curr Opin Pediatr. 2008;20:23-9.
- Feroze K, Unni M, Jayasree MG, Seethalekshmy NV. Langer- hans cell histiocytosis presenting with hypopigmented macules. Indian J Dermatol Venereol Leprol. 2008;74:670-2.
- Byragani D, Baradhi K, Schendrick I, Koya S. Langerhan cell histiocytosis: a rare disorder with a rare presentation. World J Oncol. 2015;6:335-7.
- Querings K, Starz H, Balda BR. Clinical spectrum of cutaneous Langerhans’ cell histiocytosis mimicking various diseases. Acta Derm Venereol. 2006;86:39-43.
- Hashimoto K, Schachner LA, Huneiti A, Tanaka K. Pagetoid self-healing Langerhans cell histiocytosis in an infant. Pediatr Dermatol. 1999;16:121-7.
- Mortazavi H, Ehsani A, Namazi MR, Hosseini M. Langerhans’ cell histiocytosis. Dermatol Online J. 2002;8:18.
- Stein SL, Paller AS, Haut PR, Mancini AJ. Langerhans cell histiocytosis presenting in the neonatal period: a retrospective case series. Arch Pediatr Adolesc Med. 2001;155:778-83
- Morren MA, Vanden Broecke K, Vangeebergen L, et al. Diverse cutaneous presentations of langerhans cell histiocytosis in children: a retrospective cohort study. Pediatr Blood Cancer. 2016;63:486-92.
- Esterly N, Maurer H, Gonzalez-Crussi F, Histiocytosis X. A seven-year experience at a children’s hospital. J Am Acad Dermatol. 1985;13:481.
- Sun WG, Zhong LS, Chen H. A case of adult generalized cutaneous langerhans cell histiocytosis. Ann Dermatol. 2016;28:262-4.
- Varga E, Korom I, Polyanka H, et al. BRAFV600E mutation in cutaneous lesions of patients with adult Langerhans cell histiocytosis. J Eur Acad Dermatol Venereol. 2015;29:1205-11.
- Намазова-Баранова Л.С., Баранов А.А., Кубанова А.А., и др. Атопический дерматит у детей: современные клинические рекомендации по диагностике и терапии. Вопросы современной педиатрии. 2016;15(3):279-94 [Namazova-Baranova LS, Baranov AA, Kubanova AA, et al. Atopic Dermatitis in Children: Current Clinical Guidelines for Diagnosis and Therapy. Current Pediatrics. 2016;15(3):279-94 (in Russian)]. DOI:10.15690/ vsp.v15i3.1566
- Мурашкин Н.Н., Опрятин Л.А., Епишев Р.В., и др. Зуд при атопическом дерматите: от этиологических особенностей к терапевтической тактике. Вопросы современной педиатрии. 2020;19(6):468-76 [Murashkin NN, Opryatin LA, Epishev RV, et al. Pruritus and Atopic Dermatitis: from Etiological Features to Management. Current Pediatrics. 2020;19(6):468-76 (in Russian)]. doi: 10.15690/vsp.v19i6.2151
- Мурашкин Н.Н., Материкин А.И., Амбарчян Э.Т., Епишев Р.В. Современные представления о патогенезе и принципах наружной терапии атопического дерматита у детей. Вопросы современной педиатрии. 2016;15(6):584-9 [Murashkin NN, Materikin AI, Ambarchyan ET, Epishev RV. Current Views on the Pathogenesis and Principles of External Treatment of Atopic Dermatitis in Children. Current Pediatrics. 2016;15(6):584-9 (in Russian)]. doi: 10.15690/vsp.v15i6.1655
- Мурашкин Н.Н., Епишев Р.В., Материкин А.И., и др. Механизмы формирования и возможности терапевтической коррекции стероидрезистентности у пациентов с атопическим дерматитом. Вопросы современной педиатрии. 2021;20(5):370-5 [Murashkin NN, Epishev RV, Materikin AI, et al. Mechanisms of Development and Variants of Therapeutic Management of Steroid Resistance in Patients with Atopic Dermatitis. Current Pediatrics. 2021;20(5):370-5 (in Russian)]. doi: 10.15690/vsp.v20i5.2309
Supplementary files
